Stay updated on SYNT001 Safety in Warm Autoimmune Hemolytic Anemia Clinical Trial
Sign up to get notified when there's something new on the SYNT001 Safety in Warm Autoimmune Hemolytic Anemia Clinical Trial page.

Latest updates to the SYNT001 Safety in Warm Autoimmune Hemolytic Anemia Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record for the SYNT001 study in participants with warm autoimmune hemolytic anemia is displayed, including its terminated status, study design, eligibility criteria, locations, outcome measures, and study documents.SummaryDifference46%

- Check19 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA sitewide NIH notice appears above the ClinicalTrials.gov page, linking to updates and FAQs about website changes and describing a transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer revision marker changed from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision advances from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error rather than study information.SummaryDifference0.2%

- Check60 days agoChange DetectedCurrent page shows a 403 Forbidden error, replacing the detailed study record content with a minimal header and a Home link. This blocks access to key trial details such as enrollment, eligibility, and locations.SummaryDifference17%

Stay in the know with updates to SYNT001 Safety in Warm Autoimmune Hemolytic Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SYNT001 Safety in Warm Autoimmune Hemolytic Anemia Clinical Trial page.